Trial Profile
The Impact of Dexmedetomidine on the Cardiac Electrophysiological Properties in Patients With Paroxysmal Atrial Fibrillation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 10 Feb 2016
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Paroxysmal atrial fibrillation
- Focus Therapeutic Use
- 10 Feb 2016 New trial record